Bharat Biotech will pay a royalty of 5% on the net sales of Covaxin, its Covid-19 vaccine, to Indian Council of Medical Research (ICMR).This has prompted public health and intellectual property experts to voice concerns.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3C4kQFA
via gqrds
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment